(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 1.74% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 0.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 119.46%.
Innospec's revenue in 2025 is $1,790,700,000.On average, 1 Wall Street analysts forecast IOSP's revenue for 2025 to be $45,243,536,026, with the lowest IOSP revenue forecast at $45,243,536,026, and the highest IOSP revenue forecast at $45,243,536,026.
In 2026, IOSP is forecast to generate $48,139,082,599 in revenue, with the lowest revenue forecast at $48,139,082,599 and the highest revenue forecast at $48,139,082,599.